Relevium’s BGX E-Health Secures US$20M Contract for Supplying PPE to the Canadian Market for Q1 of the Current Fiscal Year - Seite 2

The Company expects to provide more details after the fulfillment of the full contract. 

Aurelio Useche, CEO of Relevium stated “We have been working diligently in response to the ongoing global pandemic, to execute on the combined PPE supply strategy with our joint venture partners H-Source Holdings. This initial Contract marks a major milestone for both companies and validates the Joint Venture between the companies as announced on July 13, 2020”.   

BGX E-HEALTH AND H-SOURCE EXECUTE ON STRATEGIC SOURCING JV

On July 13, 2020 the Company entered into a joint venture and cooperation agreement with H-Source Holdings to develop a global strategic angle for sourcing and supplying PPE. The Company, in partnership with H-Source, has completed several multi-channel sourcing contracts in North America and South East Asia, to secure the supply chain strategy for the companies and begin the delivery of the PPE in the next two weeks. The supply chain strategy between H-Source and BGX will also ensure the fulfillment of future contracts to be acquired over the next several months as countries around the world prepare for a second wave of Covid-19.

John Kupice, CEO of H-Source stated, “We are delighted to join forces with BGX and leverage our secure platform to ensure the safe and efficient supply of PPE for the Canadian market. This contract validates the strength our JV and we look forward to build a combined strategy for further developing the global market for PPE”

About Relevium Technologies

Relevium is a publicly traded Company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly owned subsidiaries:

BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals primarily through its Bioganix brand portfolio in the US and Europe. Relevium’s premium brands are sold at some of the world’s largest retailers including Walmart.com and Amazon.com.

Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical Company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.